- OUTLOOK
Four technologies that could transform the treatment of blindness
Access options
doi: https://doi.org/10.1038/d41586-019-01107-8
This article is part of Nature Outlook: The eye, an editorially independent supplement.
References
Bourne, R. R. A. et al. Lancet Glob. Health 5, e888–e897 (2017).
Humayun, M. S. et al. Vision Res. 43, 2573–2581 (2003).
Dobelle, W. H. & Mladejovsky, M. G. J. Physiol. 243, 553–576 (1974).
Bainbridge, J. W. et al. N. Engl. J. Med. 358, 2231–2239 (2008).
Maguire, A. M. et al. N. Engl. J. Med. 358, 2240–2248 (2008).
Hauswirth, W. W. et al. Hum. Gene Ther. 19, 979–990 (2008).
Russell, S. et al. Lancet 390, 849–860 (2017).
Latella, M. C. et al. Mol. Ther. Nucleic Acids 5, e389 (2016).
Jain, A. et al. Proc. Natl Acad. Sci. USA 114, 11199–11204 (2017).
Millington-Ward, S. et al. Mol. Ther. 19, 642–649 (2011).
Cideciyan, A. V. et al. Proc. Natl Acad. Sci. USA 115, E8547–E8556 (2018).
da Cruz, L. et al. Nature Biotechnol. 36, 328–337 (2018).
Kashani, A. H. et al. Sci. Transl. Med. 10, eaao4097 (2018).
Fischer, A. J. & Reh, T. A. Nature Neurosci. 4, 247–252 (2001).
Ueki, Y. et al. Proc. Natl Acad. Sci. USA 112, 13717–13722 (2015).
Jorstad, N. L. et al. Nature 548, 103–107 (2017).